1 min read
Add as a preferred source on GoogleRallybio Sets 1-for-2 Reverse Split Ahead of Avenzo Merger
The split is scheduled to take effect at 4:01 p.m. ET on Nov. 20, with split-adjusted trading expected to begin Nov. 23.
Rallybio Corporation has approved a 1-for-2 reverse stock split ahead of its anticipated merger with Avenzo Therapeutics, Inc., with the change scheduled to take effect Nov. 20.
The split is set for 4:01 p.m. ET (21:01 UTC). Under the 1-for-2 ratio, every two existing shares will be consolidated into one share. Split-adjusted trading is expected to begin Nov. 23.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.